Literature DB >> 11173942

Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue.

H John1, A Barghorn, G Funke, T Sulser, S Hailemariam, D Hauri, H Joller-Jemelka.   

Abstract

OBJECTIVES: The aim of this prospective study was to observe immunophenotypic patterns in patients with noninflammatory chronic pelvic pain syndrome (Cat IIIB CPPS) for further description and as possible surrogate markers for diagnosis and treatment.
METHODS: Eighty-eight patients with a referral diagnosis of chronic prostatitis underwent fractionated urinary cultures including expressed prostate secretion (EPS) and ejaculate analysis twice on two occasions. Monthly serum analyses included C3c, C4, IL-1alpha, sIL-2R, and IL-6. One hundred samples from healthy individuals were used as the control group for serum analysis. Monthly ejaculate testing was done for IgG, IgA, IgM, IL-1alpha, sIL-2R, and IL-6. The control group for ejaculate analysis was composed of 96 normal ejaculates (according to the WHO criteria). Immunohistochemical detection of CD3 cells (T lymphocytes) and CD20 cells (B lymphocytes) was performed in 71 biopsy cylinders of Cat IIIB CPPS patients and in 25 prostate biopsy cylinders of men without symptoms or obstruction.
RESULTS: Complete sampling of urinary, serum and ejaculate specimens was achieved in 50/88 (57%) patients. Cat IIIB CPPS was observed in 44/50 (88%) patients. Intra-acinar T-lymphocytic infiltrates were dominated by T cytotoxic cells (p = 0.05). Immunohistochemical studies showed inflammatory expression in serum complement, serum interleukin, and ejaculate interleukin concentrations in relation to the presence of large numbers of T cells (all p values < or =0.01). No difference was found in the proportion of B lymphocytes in patients with Cat IIIB CPPS compared to the control group. Serum and ejaculate IL-6 and ejaculate IgA increased significantly and dropped again, correlating with a release of clinical symptoms.
CONCLUSIONS: Interleukin, complement and immunoglobulin determinations in serum and ejaculate reveal an inflammatory process even in Cat IIIB CPPS. The findings of intra-acinar T-cell-rich infiltrates and the associated inflammatory reaction may be a significant advance in defining Cat IIIB CPPS caused by a possible autoimmune component. Serum and ejaculate IL-6 and ejaculate IgA are possible surrogate markers for the diagnosis and treatment of Cat IIIB CPPS.

Entities:  

Mesh:

Year:  2001        PMID: 11173942     DOI: 10.1159/000052415

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  23 in total

Review 1.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

2.  The New Age of Prostatitis.

Authors:  Granville L. Lloyd; Anthony J. Schaeffer
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

Review 3.  Mechanisms of pain in chronic pelvic pain syndrome: influence of prostatic inflammation.

Authors:  Aare Mehik; Markku J Leskinen; Pekka Hellström
Journal:  World J Urol       Date:  2003-04-17       Impact factor: 4.226

4.  Circumcision plus antibiotic, anti-inflammatory, and α-blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial.

Authors:  Yuyang Zhao; Wei Zhao; Genqiang Lang; Yaowu Chen; Jianxin Liu; Guozeng Wang; Xiaobing Ma; Min Gong; Dongliang Xu; Shujie Xia
Journal:  World J Urol       Date:  2014-07-01       Impact factor: 4.226

Review 5.  [Seminal cytokines: is quantification useful in urogenital disorders?].

Authors:  A Pilatz; C Hudemann; F Wagenlehner; H-C Schuppe; T Diemer; W Weidner; H Renz; T Bschleipfer
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

Review 6.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  Mechanisms in prostatitis/chronic pelvic pain syndrome.

Authors:  Michel A Pontari; Michael R Ruggieri
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

8.  Identification of antigen-specific IgG in sera from patients with chronic prostatitis.

Authors:  Edward J Dunphy; Jens C Eickhoff; Charles H Muller; Richard E Berger; Douglas G McNeel
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

Review 9.  The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Marco Dellabella; Giulio Milanese; Sandra Sigala; Gianluca d'Anzeo; Nicola Arrighi; Serena Bodei; Giovanni Muzzonigro
Journal:  Inflamm Res       Date:  2009-12       Impact factor: 4.575

10.  Chronic prostatitis: Current concepts.

Authors:  Ram Vaidyanathan; Vibhash C Mishra
Journal:  Indian J Urol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.